COLLAGE Trademark

Trademark Overview


On Monday, October 28, 2024, a trademark application was filed for COLLAGE with the United States Patent and Trademark Office. The USPTO has given the COLLAGE trademark a serial number of 98824432. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, November 12, 2025. This trademark is owned by Collage Bio Inc.. The COLLAGE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical research and development; scientific research and development; medical research and development in the field of medical preparations; pharmaceutical research and analysis services using machine learning analytics for drug efficacy and safety; technical consultation services and product development for others in the fields of biotechnology and pharmaceuticals; pharmaceutical and scientific research and development relating to RNA targeting and assay development; platform as a service (PaaS) featuring computer software platforms for performing drug discovery and development and biotechnology research; pharmaceutical drug development services related to proteins, ribosomes, RNA, and DNA

Pharmaceutical preparations for the treatment of genetic and genomic diseases and disorders, neurological diseases and disorders, muscular diseases and disorders, neuromuscular diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, cardiometabolic diseases and disorders, endocrine diseases and disorders, and kidney diseases and disorders; pharmaceutical preparations, namely, RNA medicines, oligonucleotide therapeutics, and polynucleotide therapeutics; biopharmaceutical preparations and agents, namely, pharmaceutical preparations for the treatment of genetic and genomic diseases and disorders, neurological diseases and disorders, muscular diseases and disorders, neuromuscular diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, cardiometabolic diseases and disorders, endocrine diseases and disorders, and kidney diseases and disorders, and RNA medicines, oligonucleotide therapeutics, and polynucleotide ...
collage

General Information


Serial Number98824432
Word MarkCOLLAGE
Filing DateMonday, October 28, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, November 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 2, 2025

Trademark Statements


Goods and ServicesPharmaceutical research and development; scientific research and development; medical research and development in the field of medical preparations; pharmaceutical research and analysis services using machine learning analytics for drug efficacy and safety; technical consultation services and product development for others in the fields of biotechnology and pharmaceuticals; pharmaceutical and scientific research and development relating to RNA targeting and assay development; platform as a service (PaaS) featuring computer software platforms for performing drug discovery and development and biotechnology research; pharmaceutical drug development services related to proteins, ribosomes, RNA, and DNA
Goods and ServicesPharmaceutical preparations for the treatment of genetic and genomic diseases and disorders, neurological diseases and disorders, muscular diseases and disorders, neuromuscular diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, cardiometabolic diseases and disorders, endocrine diseases and disorders, and kidney diseases and disorders; pharmaceutical preparations, namely, RNA medicines, oligonucleotide therapeutics, and polynucleotide therapeutics; biopharmaceutical preparations and agents, namely, pharmaceutical preparations for the treatment of genetic and genomic diseases and disorders, neurological diseases and disorders, muscular diseases and disorders, neuromuscular diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, cardiometabolic diseases and disorders, endocrine diseases and disorders, and kidney diseases and disorders, and RNA medicines, oligonucleotide therapeutics, and polynucleotide therapeutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 28, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 3, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCollage Bio Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events


Event DateEvent Description
Monday, October 28, 2024NEW APPLICATION ENTERED
Sunday, April 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 29, 2025ASSIGNED TO EXAMINER
Thursday, May 8, 2025NON-FINAL ACTION WRITTEN
Thursday, May 8, 2025NON-FINAL ACTION E-MAILED
Thursday, May 8, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 7, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, August 7, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, November 3, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 4, 2025APPROVED FOR PUB - PRINCIPAL REGISTER